Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 2/2000

01-11-2000 | Original

Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes

Authors: Y. Aso, T. Inukai, K. Tayama, Y. Takemura

Published in: Acta Diabetologica | Issue 2/2000

Login to get access
Metadata
Title
Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes
Authors
Y. Aso
T. Inukai
K. Tayama
Y. Takemura
Publication date
01-11-2000
Publisher
Springer-Verlag Italia
Published in
Acta Diabetologica / Issue 2/2000
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s005920070025

Other articles of this Issue 2/2000

Acta Diabetologica 2/2000 Go to the issue

Original

Significant association between a silent polymorphism in the neuromedin B gene and body weight in German children and adolescents

Original

Synergistic effect of arcuate and raphe nuclei graft to alleviate insulinemia and obesity in Zucker rats

Original

Acute effect of physiologic hyperinsulinaemia on serum leptin concentration in healthy young people

Original

Resting metabolic rate in Italians: relation with body composition and anthropometric parameters

Original

Plasma epinephrine and norepinephrine response to stimuli in autonomic neuropathy of type 2 diabetes mellitus

Original

The effect of aminoguanidine on urinary heparan sulphate levels in experimental diabetes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits